Corrigendum to “Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system” [Contemp. Clin. Trials 64 (2018) 77–87](S1551714417304536)(10.1016/j.cct.2017.11.004)

Rachel L. Winer, Jasmin A. Tiro, Diana L. Miglioretti, Chris Thayer, Tara Beatty, John Lin, Hongyuan Gao, Kilian Kimbel, Diana S.M. Buist

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Corrigendum to “Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system” [Contemp. Clin. Trials 64 (2018) 77–87](S1551714417304536)(10.1016/j.cct.2017.11.004)'. Together they form a unique fingerprint.

Fingerprint

Medicine & Life Sciences